Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation
- 18 September 2006
- journal article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 38 (9), 621-627
- https://doi.org/10.1038/sj.bmt.1705503
Abstract
We have used a standardized 21-day expansion protocol to produce cytokine-induced killer (CIK) cells starting from very small amounts of nucleated cells (approximately 15 106 cells) isolated from cord blood. Mononuclear cells are stimulated with anti CD3 (OKT3) and IFN and then expanded with IL-2. Moreover, we show that washouts of cord blood units bags (at the end of the infusion) may be sufficient to yield almost 500 106 CIK by the same expansion protocol. CIK cells show strong cytotoxic activity against a variety of tumor target cell lines including B and T lymphomas and myeloid leukemias. More importantly, expanded cord blood-derived CIK cells are cytotoxic against fresh leukemic blasts and express perforin, granzyme and NKG2D molecule at high levels. The same in vitro protocol has already been used to expand CIK cells from peripheral blood of adult donors under GMP conditions and therefore these observations open up the possibility of imagining a future clinical application of leukemia relapse following cord blood transplantation with CIK cells obtained from the same cord blood unit.Keywords
This publication has 25 references indexed in Scilit:
- Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapyBlood, 2006
- The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D–target-cell interactionsBlood, 2005
- Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndromeEuropean Journal of Haematology, 2005
- Cord Blood Immunology and Stem Cell TransplantationHuman Immunology, 2005
- A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphomaTransplantation and Cellular Therapy, 2005
- Umbilical Cord Blood Transplantation: A New Alternative OptionHematology, 2005
- Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cellsBlood, 2004
- Herpes simplex thymidine kinase gene–transduced donor lymphocyte infusionsExperimental Hematology, 2003
- Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftBlood, 2001
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997